Learn More
Description
The CB9 monoclonal antibody specifically recognizes Granzyme A (GrA, GzmA or Gzm A) which is also known as CTL tryptase, Cytotoxic T-lymphocyte-associated serine esterase-3 (CTLA3), Cytotoxic T-lymphocyte proteinase 1, Fragmentin-1, or Hanukah factor serine protease (HFSP). Granzyme A belongs to a family of effector proteases that include five different granzymes that play key roles in innate and adaptive immune responses to pathogens and transformed cells: Granzymes A, B, H, K and M. Granzyme A is a ∼28 kDa neutral serine protease that is encoded by GZMA. It is expressed in the cytotoxic granules of natural killer (NK) cells, NKT cells, cytotoxic αâ T cells and ãä T cells. Granzyme A participates in innate and adaptive immune responses. After gaining access into target cells, Granzyme A cleaves various peptide substrates after lysine or arginine residues and can induce caspase‐independent cell death reflected in single-stranded DNA damage as well as rapid loss of cell membrane integrity and mitochondrial transmembrane potential.
Specifications
Specifications
| Antigen | Granzyme A |
| Applications | Flow Cytometry |
| Classification | Monoclonal |
| Clone | CB9 |
| Conjugate | R718 |
| Host Species | Mouse |
| Quantity | 100 Tests |
| Regulatory Status | RUO |
| Primary or Secondary | Primary |
| Target Species | Human |
| Show More |
Safety and Handling
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.